Evidence map›Paper›PMID 40651594›Full record

ReviewJournal of molecular and cellular cardiology2025

Time-restricted feeding mediated synchronization of circadian rhythms to sustain cardiovascular health.

Girish C Melkani

Abstract readReview
In one paragraph

Review in Journal of molecular and cellular cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Girish C MelkaniDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA; UAB Nathan Shock Center, Birmingham, AL 35294, USA. Electronic address: girishketone@uabmc.edu.

Funding

Dissecting Causal Role of Insomnia in Cardiovascular DiseaseR01HL146751 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MELKANI, GIRISH C., SAXENA, RICHA · 2020 to 2023
$3.6M
Molecular basis of circadian rhythms disruptions linked cardiometabolic disorders and their mitigation using dietary interventionR01AG065992 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MELKANI, GIRISH C. · 2019 to 2023
$1.9M
Promoting circadian rhythms to optimize gut-to-brain signaling for Alzheimer's diseaseRF1NS133378 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MELKANI, GIRISH C. · 2023 to 2023
$1.9M
Optimized Circadian Rhythms for the Prevention of Alzheimer's DiseaseR01AG068550 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MELKANI, GIRISH C., PANDA, SATCHIDANANDA · 2024 to 2024
$736k
NHLBI NIH HHS R01 HL146751NIA NIH HHS R01 AG065992NIA NIH HHS R01 AG068550NINDS NIH HHS RF1 NS133378
6 · The paper itself

Abstract

Circadian rhythm is critical in maintaining metabolic homeostasis, including cardiac health, with disruptions often leading to adverse cardiac outcomes. Time-restricted feeding/eating (TRF/TRE) is a dietary approach that limits food intake to specific hours during an organism's active phase, daytime for diurnal animals and nighttime for nocturnal ones. This strategy has shown promise in realigning circadian rhythms and reducing the negative effects of circadian disruption on heart function. This review examines the intricate relationship between circadian rhythms and cardiac health, highlighting the molecular mechanisms governed by central and peripheral clocks. We discuss how circadian misalignment contributes to cardiovascular disease and explore how TRF/TRE can restore circadian synchronization, particularly in the context of lipid metabolism, gene expression, and other physiological processes essential for heart function. The review also examines the impact of TRF/TRE on cardiac renovation, particularly under conditions of circadian disruption associated with cardiovascular and cardiometabolic disorders. We further explore potential molecular mechanisms, including the modulation of clock genes and lipid metabolic pathways, such as diacylglycerol O-acyltransferase 2 (DGAT2), that underpin the cardioprotective effects of TRF. By consolidating findings from genetic and translational animal models and human studies, we underscore the promise of TRF/TRE in improving cardiac outcomes and propose areas for future research. The potential of TRF/TRE as a therapeutic intervention for cardiovascular disease warrants further investigation, particularly in understanding its long-term effects on cardiac health and its integration into clinical practice.

Indexed as

Cardiovascular DiseasesCircadian RhythmFeeding BehaviorAnimalsHumansLipid MetabolismCardiovascular/cardiometabolic disordersCircadian clock/rhythmCircadian rhythm disruptionMetabolic healthTime-restricted feeding/eating

Identifiers

PMID40651594
PMCPMC13182227

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.